Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-13

Clinical Trial Update: Resveratrol Stimulates Insulin Sensitivity in Subjects With Obesity and Insulin Resistance [NA]

View source ↗

Summary

The trial update reports that resveratrol may improve insulin sensitivity in individuals with obesity and insulin resistance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Resveratrol (resveratrol)

Snippet

Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Conditions: Obesity | NA | Status: COMPLETED